67 related articles for article (PubMed ID: 1538773)
1. HLA antigens and cervical carcinoma.
Glew SS; Stern PL; Davidson JA; Dyer PA
Nature; 1992 Mar; 356(6364):22. PubMed ID: 1538773
[No Abstract] [Full Text] [Related]
2. HLA antigens and cervical carcinoma.
Wank R; Schendel DJ; Thomssen C
Nature; 1992 Mar; 356(6364):22-3. PubMed ID: 1538774
[No Abstract] [Full Text] [Related]
3. HLA antigens and cervical carcinoma.
Helland A; Børresen AL; Kaern J; Rønningen KS; Thorsby E
Nature; 1992 Mar; 356(6364):23. PubMed ID: 1538776
[No Abstract] [Full Text] [Related]
4. [Polymorphism of HLA-DRB1 and -DQB1 alleles among young women with cervical squamous cell carcinoma and its relation with human papillomavirus type 16 infection].
Hu Y; Zhang SH; Huang YG; Zhu H; Shuai CX
Zhonghua Yi Xue Za Zhi; 2010 Aug; 90(31):2193-7. PubMed ID: 21029659
[TBL] [Abstract][Full Text] [Related]
5. HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity.
Apple RJ; Erlich HA; Klitz W; Manos MM; Becker TM; Wheeler CM
Nat Genet; 1994 Feb; 6(2):157-62. PubMed ID: 8162070
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen class II alleles and risk of cervical cancer in China.
Wu Y; Liu B; Lin W; Xu Y; Li L; Zhang Y; Chen S; Lin Z; Xu A
Hum Immunol; 2007 Mar; 68(3):192-200. PubMed ID: 17349874
[TBL] [Abstract][Full Text] [Related]
7. Invasive squamous cell carcinoma of the cervix: is HLA-DQ a disease marker in Jewish patients?
Amar A; Battat S; Anteby SO; Brautbar C; Reubinoff BE
Eur J Immunogenet; 1993 Oct; 20(5):327-33. PubMed ID: 9098401
[TBL] [Abstract][Full Text] [Related]
8. HLA class II antigen expression in human papillomavirus-associated cervical cancer.
Glew SS; Duggan-Keen M; Cabrera T; Stern PL
Cancer Res; 1992 Jul; 52(14):4009-16. PubMed ID: 1377602
[TBL] [Abstract][Full Text] [Related]
9. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population.
Montoya L; Saiz I; Rey G; Vela F; Clerici-Larradet N
Eur J Immunogenet; 1998 Oct; 25(5):329-37. PubMed ID: 9805655
[TBL] [Abstract][Full Text] [Related]
10. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3.
Wank R; Thomssen C
Nature; 1991 Aug; 352(6337):723-5. PubMed ID: 1876187
[TBL] [Abstract][Full Text] [Related]
11. HLA-DRB1 alleles and cervical squamous cell carcinoma: experimental study and meta-analysis.
Yang YC; Chang TY; Lee YJ; Su TH; Dang CW; Wu CC; Liu HF; Chu CC; Lin M
Hum Immunol; 2006; 67(4-5):331-40. PubMed ID: 16720214
[TBL] [Abstract][Full Text] [Related]
12. [HLA and cervical carcinoma (author's transl)].
Aoki K; Katahira T; Takagi T; Nakane S; Yagami Y; Akaza T; Suchi T
Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jun; 34(6):677-84. PubMed ID: 6954207
[TBL] [Abstract][Full Text] [Related]
13. Cervical intraepithelial neoplasia, cervical carcinoma, and risk for patients with HLA-DQB1*0602,*301,*0303 alleles.
Wank R; Meulen JT; Luande J; Eberhardt HC; Pawlita M
Lancet; 1993 May; 341(8854):1215. PubMed ID: 8098101
[No Abstract] [Full Text] [Related]
14. Altered HLA expression by metastatic cervical carcinoma cells as a factor in impaired immune surveillance.
Hilders CG; Munoz IM; Nooyen Y; Fleuren GJ
Gynecol Oncol; 1995 Jun; 57(3):366-75. PubMed ID: 7774840
[TBL] [Abstract][Full Text] [Related]
15. Tissue evaluation of immune markers in endometrial and cervical carcinomas.
Lazaris ACh; Chatzigianni EB; Xidias G; Panoskaltsis TA; Thomopoulou GC; Eftychiadis CA; Michalas S; Patsouris ES
J Exp Clin Cancer Res; 2004 Jun; 23(2):269-75. PubMed ID: 15354412
[TBL] [Abstract][Full Text] [Related]
16. Risk of invasive cervical cancer associated with polymorphic HLA DR/DQ haplotypes.
Ghaderi M; Wallin KL; Wiklund F; Zake LN; Hallmans G; Lenner P; Dillner J; Sanjeevi CB
Int J Cancer; 2002 Aug; 100(6):698-701. PubMed ID: 12209609
[TBL] [Abstract][Full Text] [Related]
17. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
18. [A study of the expression of class II antigen on uterine cervical cancer cells and cell lines].
Okamoto Y; Ueda M; Yamada T; Misaki O; Seiki Y; Tsurunaga T; Iwai E; Ueki M; Sugimoto O
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Dec; 40(12):1819-25. PubMed ID: 2974857
[TBL] [Abstract][Full Text] [Related]
19. Human leukocyte antigen class II and cervical cancer risk: a population-based study.
Madeleine MM; Brumback B; Cushing-Haugen KL; Schwartz SM; Daling JR; Smith AG; Nelson JL; Porter P; Shera KA; McDougall JK; Galloway DA
J Infect Dis; 2002 Dec; 186(11):1565-74. PubMed ID: 12447731
[TBL] [Abstract][Full Text] [Related]
20. Decreased frequency of HLA-DRB1 13 alleles in Frenchwomen with HPV-positive carcinoma of the cervix.
Sastre-Garau X; Loste MN; Vincent-Salomon A; Favre M; Mouret E; de la Rochefordiere A; Durand JC; Tartour E; Lepage V; Charron D
Int J Cancer; 1996 Jun; 69(3):159-64. PubMed ID: 8682580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
